Premeeting Workshop:
PW5. Hepatitis C Workshop ($)
Wednesday, October 26, 2016: 8:00 AM-12:00 PM
Room: 283-285

Handouts
  • Craig Ballard - Dodging Drug Interactions.pdf (822.4 kB)
  • David Thomas - Initial Evaluation of Anti-HCV Positive Patient.pdf (635.9 kB)
  • David Wyles- When All Else Failed.pdf (302.8 kB)
  • Eliot Godofsky - Hepatology for the ID Physician.pdf (3.1 MB)
  • Javeed Siddiqui - Hello its Me - TeleMedicine and HCV Infection.pdf (5.7 MB)
  • Ronald Nahass - Strategies to Optimize Office Management of Hepatitis C.pdf (1.2 MB)

    • Learning Objectives:

    At the conclusion of this session, participants will be able to:

    • describe updated treatment guidelines
    • identify the latest drugs approved for hepatitis C virus (HCV) mono-infection and HCV-HIV co-infection
    • discuss medical problems common to HCV patients and the basics of care of the compensated cirrhotic patient
    • list new non-invasive modalities for assessment of liver damage

    Target Audience: Clinicians, Fellows, HIV clinicians, Infectious diseases physicians, Members-in-training

    Tracks: Adult ID, Epidemiology and Infection Control

    Pre-Meeting Workshop Moderators:  Eliot Godofsky, MD, FIDSA, Bach and Godofsky and David Thomas, MD, MPH, FIDSA, Johns Hopkins University School of Medicine

    Presentations:
    8:00 AM
    Introductory Remarks: Why Hepatitis C Needs ID Physicians
    8:10 AM
    W44
    First Things First: Diagnosis and Staging
    David Thomas, MD, MPH, FIDSA

    8:30 AM
    W45
    Getting It Right from the Beginning: Initial Treatment of HCV Infection
    Kristen M. Marks, MD

    9:00 AM
    W46
    When All Else Failed: RAVS and Retreatment
    David Wyles, MD

    9:30 AM
    W47
    Dodging Drug Interactions: HIV/HCV Coinfection and Other Pharmacologic Challenges
    Craig Ballard, PharmD

    10:00 AM
    W48
    Hepatology 101 for the Non-Hepatologist
    Eliot Godofsky, MD, FIDSA

    10:30 AM
    W49
    "Hello, It's Me": Telemedicine and HCV Infection
    Javeed Siddiqui, MD, MPH

    10:50 AM
    W50
    Perfecting Practice: Office Management of HCV Infection
    Ronald Nahass, MD, FIDSA, FSHEA
    11:10 AM
    I Have a Great Case (with the Panel)

    CME Credits: Maximum of 4 hours of AMA PRA Category 1 Credit™

    ACPE Credits: ACPE 4 knowledge-based contact hours .40 of pharmacy CE

    ACPE Number: 0221-9999-16-201-L02-P

    Disclosures:

    E. Godofsky, AbbVie: Consultant and Investigator , Consulting fee and Research grant
    Gilead: Investigator , Research support
    Vertex: Investigator , Research support
    Janssen: Consultant and Investigator , Consulting fee and Research support
    Trek Therapeutics: Investigator , Research support
    Merck: Investigator , Research support
    Schering-Plough: Grant Investigator , Research support

    D. Thomas, None

    See more of: Premeeting Workshop
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.